News

Tests reveal risk of passing on SCD, other diseases


 

Photo by Graham Colm

Blood samples

Quest Diagnostics has announced the US launch of QHerit™, a genetic screening service that helps people of multiple ethnicities identify their risk of passing on heritable disorders to their offspring.

The QHerit Pan-Ethnic Expanded Carrier Screen is a panel of tests for the 22 heritable diseases cited in new screening guidelines from the American College of Gynecology (ACOG).

Among the diseases are alpha-thalassemia, Fanconi anemia, and beta-hemoglobinopathies, including sickle cell disease (SCD).

Traditionally, genetic carrier screening has been used for at-risk populations based on specific ancestry assumptions and focused on only a few likely disorders with higher prevalence associated with that ethnicity.

In its new guidelines, ACOG recommends offering pan-ethnic, expanded carrier, and ethnic-specific screening for all women considering pregnancy. The guidelines also state that the partner of a woman who tests positive may be a candidate for screening.

QHerit screens women and men for clinically relevant variants of genes for disorders that could have potentially devastating consequences, result in early death, or create a need for significant early intervention.

The disorders covered by QHerit include:

Disease Race/ethnicity
Alpha-thalassemia Mediterranean, Middle East, Southeast Asian, African, Chinese, Asian Indian
Beta-

hemoglobinopathies

(including SCD)

Mediterranean, Middle East, Southeast Asian, African, Chinese, Asian Indian
Bloom syndrome Ashkenazi Jewish descent (AJ)
Canavan disease AJ and non-AJ
Cystic fibrosis African American, AJ, Asian American, Hispanic American, non-Hispanic Caucasian
Dihydrolipoamide

dehydrogenase

deficiency

AJ
Familial dysautonomia AJ
Familial hyperinsulinism AJ
Fanconi anemia Type C AJ
Fragile X syndrome Females
Gaucher disease AJ
Glycogen storage

disease Type Ia

AJ, Caucasian
Joubert syndrome 2 AJ
Maple syrup urine

disease

AJ
Mucolipidosis Type IV AJ
Nemaline myopathy AJ
Niemann-Pick

disease Types A & B

AJ
Spinal muscular

atrophy

African American, AJ, Asian, Caucasian, Hispanic
Tay-Sachs disease AJ, French Canadian, general population
Usher syndrome,

Type IF

AJ
Usher syndrome,

Type IIIA

AJ
Walker-Warburg

syndrome

AJ

QHerit is now available for order by US physicians. For more information, visit www.QHerit.com.

Recommended Reading

FDA approves first new drug for sickle cell in nearly 20 years
MDedge Hematology and Oncology
Allele-matching in cord blood transplant yields better survival
MDedge Hematology and Oncology
Predicting response to azacitidine in MDS
MDedge Hematology and Oncology
Mutations linked to Fanconi anemia
MDedge Hematology and Oncology
Studies support testing for iron deficiency in young women
MDedge Hematology and Oncology
Vaccine granted orphan designation for MDS
MDedge Hematology and Oncology
FDA approves new treatment for sickle cell disease
MDedge Hematology and Oncology
Luspatercept appears safe, effective in β-thalassemia
MDedge Hematology and Oncology
FDA clears use of reagents to detect hematopoietic neoplasia
MDedge Hematology and Oncology
SCD therapy granted access to PRIME program
MDedge Hematology and Oncology